Clinical Trials Browser

Phase 2 × tamibarotene × Thoracic × Clear all

NCT01337154 2013-06-28

First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung